GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 88 filers reported holding GLYCOMIMETICS INC in Q2 2020. The put-call ratio across all filers is 5.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $578,000 | -91.9% | 253,516 | -81.1% | 0.02% | -90.6% |
| Q4 2019 | $7,109,000 | -17.4% | 1,343,845 | -32.7% | 0.17% | -41.0% |
| Q3 2019 | $8,610,000 | -64.0% | 1,997,647 | -0.5% | 0.29% | -57.5% |
| Q2 2019 | $23,941,000 | -4.8% | 2,008,447 | -0.5% | 0.68% | -8.0% |
| Q1 2019 | $25,147,000 | +34.2% | 2,018,247 | +2.0% | 0.74% | -2.4% |
| Q4 2018 | $18,737,000 | -36.5% | 1,978,547 | -3.4% | 0.75% | -16.9% |
| Q3 2018 | $29,493,000 | -9.9% | 2,048,147 | +0.9% | 0.91% | -18.4% |
| Q2 2018 | $32,733,000 | -11.6% | 2,029,347 | -11.1% | 1.11% | -22.2% |
| Q1 2018 | $37,041,000 | +14.3% | 2,282,268 | +18.2% | 1.43% | +1.5% |
| Q4 2017 | $32,416,000 | +90.9% | 1,930,668 | +59.0% | 1.41% | +68.1% |
| Q3 2017 | $16,985,000 | +153.8% | 1,214,088 | +102.5% | 0.84% | +105.9% |
| Q2 2017 | $6,692,000 | – | 599,620 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $31,729,000 | 3.33% |
| NEA Management Company, LLC | 9,089,041 | $39,174,000 | 3.24% |
| Camber Capital Management LP | 3,500,000 | $15,085,000 | 0.79% |
| Redmile Group, LLC | 1,997,647 | $8,610,000 | 0.29% |
| Alambic Investment Management, L.P. | 41,698 | $180,000 | 0.14% |
| CAXTON CORP | 26,575 | $115,000 | 0.13% |
| PRENTISS SMITH & CO INC | 17,000 | $73,000 | 0.05% |
| Virtus ETF Advisers LLC | 22,580 | $97,000 | 0.02% |
| AXA S.A. | 1,825,738 | $7,868,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,000 | $129,000 | 0.01% |